Five things to know:
- Allscripts is seeking acquisitions that increase its payer and life sciences work with its Veradigm business.
- Allscripts will use the proceeds from the sale of its hospital and large physician practices division to assist Veradigm with new life sciences and payer acquisitions.
- Allscripts reported $150.9 million in income for 2022’s second quarter, up 6.9 percent from the same quarter in 2021.
- Veradigm contributed $144.6 million in income, up 8.4 percent year-over-year.
- Allscripts posted a $5.4 million working loss for the quarter.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
